132 related articles for article (PubMed ID: 35951471)
1. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.
Rodrigo JP; Rodríguez-Santamarta T; Corte D; García-de-la-Fuente V; Rodríguez-Torres N; Lequerica-Fernández P; Lorz C; García-Pedrero JM; de Vicente JC
Oral Dis; 2024 Mar; 30(2):149-162. PubMed ID: 35951471
[TBL] [Abstract][Full Text] [Related]
2. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
Liu L; Lu Z; Hu X; Su T; Su L; Pu H
Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
6. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
7. The role of Hippo-YAP signaling in squamous cell carcinomas.
Maehama T; Nishio M; Otani J; Mak TW; Suzuki A
Cancer Sci; 2021 Jan; 112(1):51-60. PubMed ID: 33159406
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of YAP and TAZ proteins in oral squamous cell carcinoma].
Tu MS; Li YS; Zhang X
Shanghai Kou Qiang Yi Xue; 2018 Aug; 27(4):415-418. PubMed ID: 30483712
[TBL] [Abstract][Full Text] [Related]
9. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
[TBL] [Abstract][Full Text] [Related]
10. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
11. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.
Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q
PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cytoplasmic p27 in oral squamous cell carcinoma.
Vallonthaiel AG; Singh MK; Dinda AK; Kakkar A; Thakar A; Das SN
J Oral Pathol Med; 2016 Aug; 45(7):475-80. PubMed ID: 26750594
[TBL] [Abstract][Full Text] [Related]
15. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
19. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
[TBL] [Abstract][Full Text] [Related]
20. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.
Chen N; Golczer G; Ghose S; Lin B; Langenbucher A; Webb J; Bhanot H; Abt NB; Lin D; Varvares M; Sattler M; Egloff AM; Joh R; Uppaluri R; Emerick KS; Lawrence MS; Saladi SV
Cell Rep; 2022 Jun; 39(11):110970. PubMed ID: 35705032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]